Privia Health Group, Inc. (NASDAQ:PRVA) Shares Sold by Guidance Capital Inc.

Guidance Capital Inc. cut its holdings in Privia Health Group, Inc. (NASDAQ:PRVA) by 11.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 22,822 shares of the company’s stock after selling 2,841 shares during the period. Guidance Capital Inc.’s holdings in Privia Health Group were worth $446,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. KBC Group NV raised its stake in Privia Health Group by 48.1% in the fourth quarter. KBC Group NV now owns 5,012 shares of the company’s stock valued at $98,000 after buying an additional 1,627 shares in the last quarter. Fifth Third Bancorp raised its stake in Privia Health Group by 38.3% in the fourth quarter. Fifth Third Bancorp now owns 5,105 shares of the company’s stock valued at $100,000 after buying an additional 1,415 shares in the last quarter. Riverbridge Partners LLC grew its holdings in shares of Privia Health Group by 19.7% during the fourth quarter. Riverbridge Partners LLC now owns 5,824,458 shares of the company’s stock worth $113,868,000 after purchasing an additional 958,418 shares during the last quarter. Nisa Investment Advisors LLC grew its holdings in shares of Privia Health Group by 185.7% during the fourth quarter. Nisa Investment Advisors LLC now owns 4,999 shares of the company’s stock worth $98,000 after purchasing an additional 3,249 shares during the last quarter. Finally, Financial Management Professionals Inc. purchased a new position in shares of Privia Health Group during the fourth quarter worth about $51,000. 94.48% of the stock is currently owned by institutional investors and hedge funds.

Privia Health Group Trading Up 0.9 %

PRVA stock opened at $23.38 on Thursday. The firm has a 50 day moving average of $21.30 and a 200-day moving average of $20.05. Privia Health Group, Inc. has a 12-month low of $15.92 and a 12-month high of $23.62. The company has a market cap of $2.81 billion, a price-to-earnings ratio of 233.82, a PEG ratio of 3.09 and a beta of 0.87.

Analysts Set New Price Targets

Several equities analysts have issued reports on PRVA shares. JPMorgan Chase & Co. raised their price objective on Privia Health Group from $27.00 to $28.00 and gave the stock an “overweight” rating in a report on Friday, November 29th. Truist Financial raised their price objective on Privia Health Group from $24.00 to $27.00 and gave the stock a “buy” rating in a report on Friday, November 8th. Barclays raised their price objective on Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a report on Friday, November 8th. Macquarie started coverage on Privia Health Group in a report on Monday, December 16th. They set an “outperform” rating and a $25.00 price objective on the stock. Finally, KeyCorp assumed coverage on Privia Health Group in a report on Friday, October 11th. They set an “overweight” rating and a $23.00 price objective on the stock. Two investment analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, Privia Health Group presently has a consensus rating of “Buy” and an average price target of $24.88.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.